Skip to main content

Advertisement

SpringerLink
Log in

Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response?

  • Invited Commentary
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Over the past several years, research in the field of cytokine production and function has become indispensable to understand the immunopathology of chronic intestinal inflammation. Thereupon, clinical studies analyzing cytokine production have generated a tremendous amount of data. In patients with inflammatory bowel disease, several studies examined pro-inflammatory cytokines in gut tissue and plasma, but a clear interpretation of the results with respect to disease activity or therapeutic response has been hampered by patient- and sample-related pitfalls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205

    Article  PubMed  CAS  Google Scholar 

  2. Gotteland M, Lopez M, Munoz C, Saez R, Altshiller H, Llorens P, Brunser O (1999) Local and systemic liberation of proinflammatory cytokines in ulcerative colitis. Dig Dis Sci 44:830–835

    Article  PubMed  CAS  Google Scholar 

  3. Gross V, Andus T, Ceasar I, Roth M, Schoelmerich J (1992) Evidence for continuous stimulation of interleukin-6 production in Crohn’s disease. Gastroenterology 102:514–519

    PubMed  CAS  Google Scholar 

  4. Kusugami K, Ina K, Ando T, Hibi K, Nishio Y, Goto H (2004) Immunomodulatory therapy for inflammatory bowel disease. J Gastroenterol 39:1129–1137

    Article  PubMed  Google Scholar 

  5. Lieberman BY, Fiocchi C, Youngman KR, Sapatnekar WK, Proffit MR (1988) Interferon-g production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci 33:1297–1304

    Article  PubMed  CAS  Google Scholar 

  6. Lochs H, Adler G, Beglinger C, Duchmann R, Emmrich J, Ewe K, Gangl A, Gasche C, Hahn E, Hoffmann P, Kaskas B, Malchow H, Pohl C, Raedler A, Renner E, Schölmerich J, Schreiber S, Stange E, Tilg H, Vogelsang H, Weigert N, Zeitz M (1999) Anti-TNF antibody in Crohn’s disease—status of information, comments and recommendations of an international working group. Z Gastroenterol 37:509–512

    PubMed  CAS  Google Scholar 

  7. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ (1991) High circulating concentrations of interleukin-6 in active Crohn’s disease but not ulcerative colitis. Gut 32:1531–1534

    Article  PubMed  CAS  Google Scholar 

  8. Matsuura T, West GA, Kleins JS, Ferraris L, Fiocchi L (1992) Soluble interleukin-2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology 102:2006–2014

    PubMed  CAS  Google Scholar 

  9. Mitsuyama K, Suzuki A, Matsumoto S, Tomiyasu N, Takaki K, Takedatsu H, Masuda J, Handa K, Harada K, Nishida H, Toyonaga A, Sata M (2005) Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis. Clin Exp Immunol 141:130–140

    Article  PubMed  CAS  Google Scholar 

  10. Muratov V, Lundahl J, Ulfgren A, Elvin K, Fehrman I, Ahlborg N, Ost A, Hittel N, Saniabadi A, Lofberg R (2005) Downregulation of interferon-g parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease. A 12-month follow-up study. Int J Colorectal Dis (in press) http://dx.doi.org/10.1007/s00384-005-0069-2

  11. Niederau C, Backmerhoff F, Schumacher B, Christoph N (1997) Inflammatory mediators and acute phase proteins in patients with Crohn’s disease and ulcerative colitis. Hepatogastroenterology 44:90–107

    PubMed  CAS  Google Scholar 

  12. Ogura Y, Imamura Y, Murakami Y, Takesue Y, Yokoyama T, Sueda T, Hiyama E (2005) Intracellular cytokine patterns of peripheral blood T cells as a useful indicator of activeness of Crohn’ disease. Hiroshima J Med Sci 54:1–8

    PubMed  CAS  Google Scholar 

  13. Raddatz D, Bockemuhl M, Ramadori G (2005) Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol 17:547–557

    Article  PubMed  CAS  Google Scholar 

  14. Rogler G (2004) Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 20:311–317

    Article  PubMed  Google Scholar 

  15. Sartor RB (1994) Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106:533–539

    PubMed  CAS  Google Scholar 

  16. Sawada K, Muto T, Shimoyama T, Satomi M, Sawada T, Nagawa H, Hiwatashi N, Asakura H, Hibi T (2003) Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 9:307–321

    Article  PubMed  CAS  Google Scholar 

  17. Shinoda T (2002) Photopheresis and leukocytapheresis: cytapheresis treatment against immune-mediated diseases. Ther Apher 6:245–246

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charite Universitätsmedizin Berlin, Campus Benjamin Franklin, Medical Clinic 1 (Gastroenterology, Rheumatology, Infectiology), Hindenburgdamm 30, 12200, Berlin, Germany

    B. M. Wittig & M. Zeitz

Authors
  1. B. M. Wittig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Zeitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. M. Wittig.

Additional information

This commentary refers to the article http://dx.doi.org/10.1007/s00384-005-0069-2

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wittig, B.M., Zeitz, M. Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response?. Int J Colorectal Dis 21, 505–507 (2006). https://doi.org/10.1007/s00384-005-0082-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-005-0082-5

Keywords

Search

Navigation